The Risk of Immune Thrombocytopenic Purpura After Vaccination in Children and Adolescents

The risk of immune thrombocytopenic purpura (ITP) after childhood vaccines other than measles-mumps-rubella vaccine (MMR) is unknown. Using data from 5 managed care organizations for 2000 to 2009, we identified a cohort of 1.8 million children ages 6 weeks to 17 years. Potential ITP cases were ident...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics (Evanston) 2012-02, Vol.129 (2), p.248-255
Hauptverfasser:	O'LEARY, Sean T, GLANZ, Jason M, BALL, Robert, MCCLURE, David L, AKHTAR, Aysha, DALEY, Matthew F, NAKASATO, Cynthia, BAXTER, Roger, DAVIS, Robert L, IZURIETA, Hector S, LIEU, Tracy A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adverse and side effects Adverse drug reactions Biological and medical sciences Blood platelets Causes of Chickenpox Vaccine - adverse effects Chickenpox Vaccine - immunology Child Child, Preschool Children & youth Cohort Studies Complications and side effects Diphtheria-Tetanus-acellular Pertussis Vaccines - adverse effects Diphtheria-Tetanus-acellular Pertussis Vaccines - immunology Drugs Female General aspects Hematologic and hematopoietic diseases Hepatitis A Vaccines - adverse effects Hepatitis A Vaccines - immunology Humans Immunization Infant Male Medical sciences Pediatrics Platelet diseases and coagulopathies Prevention and actions Public health. Hygiene Public health. Hygiene-occupational medicine Purpura, Thrombocytopenic, Idiopathic - epidemiology Purpura, Thrombocytopenic, Idiopathic - etiology Retrospective Studies Risk Risk assessment Thrombocytopenic purpura United States Vaccination Vaccination - adverse effects Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!